YOLFTbeta
Laobaixing Pharmacy

Laobaixing Pharmacy

603883 · SHG · Healthcare / Pharmaceutical Retailers

14.26CNY-0.07 (-0.49%)

Price History

Full chart

Market Stats

Previous Close14.33
Open14.28
Day Range14.16 – 14.49
52-Week Range10.42 – 17.96
Volume7.40M
Market Cap9.90B
P/E (TTM)22.88
Forward P/E0.00
EPS0.57
Dividend Yield5.44%
Beta0.44
50-Day Avg12.96
200-Day Avg13.53

About

LBX Pharmacy Chain Joint Stock Company operates a chain of pharmacy stores in Mainland China. The company operates through three segments: Retail business, Wholesale business, and Other. It engages in commodity retail and wholesale business; and pharmaceutical manufacturing business and others, as well as sells drugs, and other health and beauty-related products through its marketing network. The company is also involved in wholesale and retail of pharmaceutical products; Chinese medicine research and development; e-commerce; food and department store retail; commodity wholesale; and retail of maternal and infant products. In addition, it provides business, information technology consulting, pharmaceutical internet information, information consulting, clinic, and medical services. The company was formerly known as Laobaixing Pharmacy Chain Joint Stock Company. LBX Pharmacy Chain Joint Stock Company was founded in 2001 and is headquartered in Changsha, China.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEOMr. Zilong Xie
  • Employees36.89K
  • HeadquartersNo. 808, Qingzhuhu Road, Changsha, China, 410152, China
  • Websitehttps://www.lbxdrugs.com

Leadership

  • Mr. Zilong XieChairman & President · b. 1966
  • Mr. Lishan ChenVP & CFO · b. 1979
  • Mr. Xin WanVice President · b. 1984
  • Ms. Shini FengVP & Company Secretary · b. 1985
  • Mr. Shiyong SuVice President · b. 1975
  • Mr. Wenshuai ZhangVice President · b. 1986
  • Ms. Xian DangVice President · b. 1981
  • Ms. Huan LinVice President · b. 1982
  • Shi LeiHead of Accounting

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.47B2.84B3.32B3.94B4.57B6.09B7.50B9.47B11.66B13.97B15.70B20.18B22.44B22.36B22.24B
Growth (%)-+15.18%+16.88%+18.72%+15.87%+33.40%+23.09%+26.26%+23.15%+19.75%+12.38%+28.54%+11.21%-0.36%-0.54%
Cost of Revenue1.63B1.84B2.13B2.46B2.84B3.86B4.86B6.14B7.75B9.51B10.66B13.75B15.16B14.95B15.05B
Gross Profit836.17M998.94M1.19B1.48B1.73B2.24B2.64B3.33B3.91B4.46B5.04B6.42B7.28B7.41B7.18B
Gross Margin33.89%35.15%35.92%37.64%37.85%36.70%35.23%35.18%33.54%31.94%32.09%31.84%32.45%33.15%32.30%
Operating Expense673.52M779.56M945.16M1.18B1.38B1.83B2.15B2.70B3.15B3.50B4.08B5.22B5.88B6.50B6.04B
Operating Income162.66M219.38M247.76M302.48M348.24M406.39M488.32M628.86M765.07M959.51M956.46M1.21B1.40B913.57M1.14B
Operating Margin6.59%7.72%7.46%7.67%7.62%6.67%6.51%6.64%6.56%6.87%6.09%5.98%6.23%4.09%5.15%
EBITDA173.83M247.26M293.82M360.02M395.82M495.12M577.06M730.52M883.62M1.04B1.16B1.53B1.66B1.34B2.32B
EBITDA Margin7.05%8.70%8.85%9.13%8.66%8.12%7.69%7.71%7.58%7.42%7.40%7.60%7.41%6.01%10.46%
Net Income98.96M125.04M160.72M202.38M240.50M296.90M370.80M435.04M508.71M621.09M669.24M784.96M929.02M519.06M381.85M
Net Income Margin4.01%4.40%4.84%5.13%5.26%4.87%4.94%4.59%4.36%4.45%4.26%3.89%4.14%2.32%1.72%
R&D----998.51K998.51K998.51K6.23M1.36M150.00K-2.23M2.51M2.01M51.07M
R&D as % of Total Revenue----0.02%0.02%0.01%0.07%0.01%0.00%-0.01%0.01%0.01%0.23%
Interest Expense6.55M19.72M19.46M29.27M19.72M37.94M64.30M59.73M76.05M75.30M203.87M245.46M185.60M191.88M130.27M
Interest Expense % of Total Revenue0.27%0.69%0.59%0.74%0.43%0.62%0.86%0.63%0.65%0.54%1.30%1.22%0.83%0.86%0.59%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.52B1.62B2.18B2.53B3.80B4.91B6.70B8.48B9.92B11.28B16.96B21.40B21.23B22.16B19.85B
Total Liabilities912.83M882.72M1.26B1.44B1.51B2.96B3.60B5.12B6.05B6.48B12.18B14.30B13.94B14.99B12.85B
Total Equity538.05M649.09M809.81M967.92M2.22B1.85B2.93B3.05B3.49B4.29B4.36B6.53B6.70B6.58B6.54B
Cash372.94M361.37M391.00M466.40M784.09M835.39M1.35B1.12B1.39B1.37B1.41B2.41B1.97B2.38B2.36B
Total Debt210.00M190.00M314.93M346.31M105.00M1.27B1.07B1.71B1.85B1.30B6.03B5.46B5.03B10.34B-
Net Debt-162.94M-171.37M-76.06M-120.09M-679.09M437.82M-280.17M588.87M462.82M-67.40M4.62B3.04B3.06B7.96B-

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow132.62M148.85M136.52M247.14M257.15M313.26M492.13M913.03M1.03B1.45B2.30B2.31B2.73B2.03B3.14B
Investing Cash Flow-186.75M-114.92M-242.82M-213.62M-567.65M-586.10M-629.09M-1.41B-837.55M-1.01B-2.00B-1.46B-761.26M-721.54M-
Financing Cash Flow139.07M-64.56M86.94M-36.23M663.05M345.81M524.30M218.06M-95.77M-495.20M-413.21M-142.62M-2.43B-1.25B-
Capital Expenditure35.32M65.10M72.06M117.63M148.17M205.66M305.12M873.41M426.40M394.27M478.61M308.44M620.87M507.50M253.44M
Free Cash Flow97.30M83.75M64.46M129.52M108.98M107.59M187.01M39.62M606.13M1.05B1.82B2.01B2.11B1.52B2.89B
Dividends Paid4.59M26.97M14.31M50.48M5.46M91.63M128.68M337.95M143.28M122.57M143.04M223.98M374.71M637.37M224.62M
FCF to OCF73.37%56.26%47.21%52.40%42.38%34.35%38.00%4.34%58.70%72.76%79.18%86.67%77.26%74.96%91.94%
Dividend Paid to FCF4.71%32.20%22.21%38.97%5.01%85.16%68.81%852.97%23.64%11.64%7.86%11.17%17.77%41.96%7.77%

Earnings

Report DateOct 28, 2015Mar 24, 2016Apr 19, 2016Aug 17, 2016Oct 28, 2016Mar 24, 2017Apr 28, 2017Aug 29, 2017Oct 30, 2017Mar 29, 2018Apr 20, 2018Aug 30, 2018Oct 24, 2018Apr 29, 2019Aug 28, 2019Oct 30, 2019Apr 27, 2020Aug 20, 2020Oct 29, 2020Apr 27, 2021Aug 16, 2021Oct 29, 2021Dec 31, 2021Apr 28, 2022Aug 29, 2022Oct 28, 2022Dec 31, 2022Apr 27, 2023Aug 30, 2023Oct 30, 2023Feb 27, 2024Apr 29, 2024Aug 29, 2024Oct 29, 2024Apr 29, 2025Aug 25, 2025Oct 28, 2025Dec 31, 2025Apr 22, 2026Aug 27, 2026
EPS Estimate----------------0.19-0.210.210.250.350.190.220.260.280.340.260.430.230.360.250.320.270.240.270.190.220.220.23
EPS Actual0.090.160.160.140.130.180.230.160.170.190.460.320.260.210.210.240.150.270.200.150.270.240.260.140.620.200.310.240.380.200.370.270.110.17-0.150.190.17-0.200.350.24
Surprise-----------------21.05%--4.76%-28.57%8.00%-31.43%36.84%-36.36%138.46%-28.57%-8.82%-7.69%-11.63%-13.04%2.78%8.00%-65.63%-37.04%-162.50%-29.63%-10.53%-190.74%59.09%4.35%
TimingAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-market-After-hoursPre-marketAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-market-Pre-marketPre-market

Key Statistics & Ratios

Market Cap9.90B
Enterprise Value11.42B
Trailing P/E22.88
Forward P/E0.00
Price / Sales0.44
Price / Book1.40
EPS0.57
Book Value9.20
Revenue (TTM)22.46B
Gross Profit (TTM)7.18B
EBITDA1.28B
Profit Margin1.92%
Operating Margin5.80%
Return on Equity8.00%
Return on Assets3.68%
Shares Outstanding758.89M
Shares Float379.21M
Beta0.44
Dividend Yield5.44%
Dividend Rate0.71
Payout Ratio85.96%

Dividends

20231×
0.50Jul 7, 2023
20221×
0.50Jun 30, 2022
20211×
0.27Jun 30, 2021
20201×
0.32Aug 21, 2020
20191×
0.27Jul 22, 2019
20181×
0.55May 17, 2018
20171×
0.16Jun 21, 2017
20161×
0.16Jul 5, 2016

Stock Splits

  • Jun 30, 202213:10
  • Aug 21, 20207:5